NLS CDMO

Business article - July 24, 2024

AGC Biologics completes Copenhagen campus expansion

The company estimates this will create several hundred more jobs, which they will begin filling this year. The grand opening of the new facility, held on June 18th, hosted elected officials and leaders from the Danish political and life science community, including the Ministry of Taxation, the Japanese Ministry in Denmark, and the Mayor of […]

CDMO - April 15, 2024

Curida secures equity investment and appoints new CEO

Curida Holding has announced a significant growth investment from Signet Healthcare Partners, a New York-based healthcare private equity firm together with existing shareholders, Canica, Investinor, Klaveness Marine and Farvatn Private Equity. This investment will enable Curida to accelerate its expansion plans, including enhancing facility capabilities and growing its industry position, it states. The total investment […]

Acquisition - April 10, 2024

Recipharm sell seven of its sites to Blue Wolf Capital Partners

The US-based private equity firm has committed to acquire Recipharm’s sites in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain. The colleagues at those sites form a new organisation under the leadership of Peter Kruger, Group Managing Director, states Recipharm. “The consolidation of our sites network […]

Acquisition - February 6, 2024

Novo Holdings to acquire Catalent

Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at USD 16.5 billion on an enterprise value basis. Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, will acquire all outstanding shares of CDMO Catalent for USD 63.50 per share […]

CDMO - January 15, 2024

Sneak peak from the hub – how does it work? 

Charlotte Fribert (CF), CEO of Toleranzia, and Niranjan Sardesai (NS), founder and CEO of Geneos Therapeutics, were among the delegates partaking in the future of advanced biologics conference (September 2023) that already tried out the innovation hub approach for real. In a brief interview, Helena Strigård gathered some of their thoughts. The projects that your […]

CDMO - October 9, 2023

Column: Playing it safe in manufacturing of advanced biologics

The very title of this article is probably a contradiction in terms. There are few other industries where manufacturing is more complex than for advanced biologics – the kind of drugs and treatments that build upon cell and gene therapies, and tissue engineered products. The manufacturing process, once you are ready for human clinical studies, […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.